The mRNA technology behind Moderna’s Covid vaccine reaches the flu
The mFlusiva vaccine for older people is first made with mRNA platform key to ending coronavirus pandemic The Food and Drug Administration has approved a
The mFlusiva vaccine for older people is first made with mRNA platform key to ending coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid 19 pandemic, Moderna, the manufacturer, said.
The shot, named mFlusiva, is intended for adults aged 50 or older. Other brands of flu shots already have begun arriving in pharmacies ahead of
fall vaccination season, and Moderna said late on Wednesday that it expected some of its new version to be available soon at select retailers. Continue
reading...
The BriefWire